New inhibitors of BRD4 identified by combining fragment-based and HTS approaches

被引：0
|
作者：
Borysko, Petro [2 ]
Vasykhenko, Olexander [1 ]
Zozulya, Sergey [2 ]
Moroz, Yurii [1 ]
机构：
[1] Natl Taras Shevchenko Univ Kyiv, ChemBioCtr, Kiev, Ukraine
[2] Enamine Ltd, Bienta, Kiev, Ukraine
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2018年 / 255卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
124
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Discovery of BRD4 bromodomain inhibitors by fragment-based high-throughput docking
    Zhao, Hongtao
    Gartenmann, Lisa
    Dong, Jing
    Spiliotopoulos, Dimitrios
    Caflisch, Amedeo
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (11) : 2493 - 2496
  • [2] Fragment-Based Drug Discovery of 2-Thiazolidinones as Inhibitors of the Histone Reader BRD4 Bromodomain
    Zhao, Lele
    Cao, Danyan
    Chen, Tiantian
    Wang, Yingqing
    Miao, Zehong
    Xu, Yechun
    Chen, Wuyan
    Wang, Xin
    Li, Yardian
    Du, Zhiyan
    Xiong, Bing
    Li, Jian
    Xu, Chunyan
    Zhang, Naixia
    He, Jianhua
    Shen, Jingkang
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (10) : 3833 - 3851
  • [3] Straightforward hit identification approach in fragment-based discovery of bromodomain-containing protein 4 (BRD4) inhibitors
    Borysko, Petro
    Moroz, Yurii S.
    Vasylchenko, Oleksandr V.
    Hurmach, Vasyl V.
    Starodubtseva, Anastasia
    Stefanishena, Natalia
    Nesteruk, Kateryna
    Zozulya, Sergey
    Kondratov, Ivan S.
    Grygorenko, Oleksandr O.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (12) : 3399 - 3405
  • [4] Fragment-Based Drug Discovery of 2-Thiazolidinones as BRD4 Inhibitors: 2. Structure-Based Optimization
    Zhao, Lele
    Wang, Yingqing
    Cao, Danyan
    Chen, Tiantian
    Wang, Qi
    Li, Yanlian
    Xu, Yechun
    Zhang, Naixia
    Wang, Xin
    Chen, Danqi
    Chen, Lin
    Chen, Yue-Lei
    Xia, Guangxin
    Shi, Zhe
    Liu, Yu-Chih
    Lin, Yijyun
    Miao, Zehong
    Shen, Jingkang
    Xiong, Bing
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (03) : 1281 - 1297
  • [5] Parallel approaches to the discovery of novel BRD4 inhibitors
    Jones, David H.
    de Groot, Marcel J.
    Heald, Robert
    Arhin, Ebenezer
    Goodwin, Ria
    Burton, Brenda
    Kulagowski, Jan
    Brown, David
    Irving, Steven
    Bazin, Richard
    Bruce, Deborah
    Devos, Rene
    Price, Steven
    Ray, Nick
    Lockey, Peter
    Montana, John
    Albertella, Mark R.
    Green, Simon R.
    CANCER RESEARCH, 2014, 74 (19)
  • [6] Fragment-Based Approaches to the Discovery of Kinase Inhibitors
    Mortenson, Paul N.
    Berdini, Valerio
    O'Reilly, Marc
    PROTEIN KINASE INHIBITORS IN RESEARCH AND MEDICINE, 2014, 548 : 69 - 92
  • [7] Dual-target Inhibitors Based on BRD4: Novel Therapeutic Approaches for Cancer
    Zhang, Sitao
    Chen, Yanzhao
    Tian, Chengsen
    He, Yujing
    Tian, Zeru
    Wan, Yichao
    Liu, Tingting
    CURRENT MEDICINAL CHEMISTRY, 2021, 28 (09) : 1775 - 1795
  • [8] Fragment-based approaches to type 2 kinase inhibitors
    Johnson, Christopher
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [9] Fragment-based Discovery of S100B Inhibitors Combining Computational and Biophysical Approaches
    Mangani, Stefano
    Cesari, Lucia
    Andreini, Matteo
    Lalli, Daniela
    del Conte, Rebecca
    Turano, Paola
    Padova, Alessandro
    Agamennone, Mariangela
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2009, 65 : S302 - S303
  • [10] BRD4 inhibitors block telomere elongation
    Wang, Steven
    Pike, Alexandra M.
    Lee, Stella S.
    Strong, Margaret A.
    Connelly, Carla J.
    Greider, Carol W.
    NUCLEIC ACIDS RESEARCH, 2017, 45 (14) : 8403 - 8410
12345